Related references
Note: Only part of the references are listed.Development of novel water-soluble photocleavable protective group and its application for design of photoresponsive paclitaxel prodrugs
Mayo Noguchi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Prodrug strategies in anticancer chemotherapy
Felix Kratz et al.
CHEMMEDCHEM (2008)
A model for light-triggered porphyrin anticancer prodrugs based on an o-nitrobenzyl photolabile group
Weiying Lin et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2008)
Synthesis, characterization, and properties evaluation of methylcoumarin end-functionalized poly(methyl methacrylate) for photoinduced drug release
Carsten Sinkel et al.
MACROMOLECULES (2008)
Prodrugs: design and clinical applications
Jarkko Rautio et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Making light work of drug release
Simon Hadlington
CHEMISTRY WORLD (2007)
Light-triggered molecule-scale drug dosing devices
Colin P. McCoy et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Targeting cytochrome P450 enzymes: A new approach in anti-cancer drug development
Robert D. Bruno et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Current molecular design of intelligent drugs and imaging probes targeting tumor-specic microenvironments
Kazuhito Tanabe et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2007)
Rational design of a dual-mode optical and chemical prodrug
Colin P. McCoy et al.
PHARMACEUTICAL RESEARCH (2007)
Development of first photoresponsive prodrug of paclitaxel
Mariusz Skwarczynski et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Synthesis and DNA cleavage reaction characteristics of enediyne prodrugs activated via an allylic rearrangement by base or UV irradiation
Y Tachi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Hypoxia-activated anticancer drugs
WA Denny
EXPERT OPINION ON THERAPEUTIC PATENTS (2005)
Hypoxia-selective activation of 5-fluorodeoxyuridine prodrug possessing indolequinone structure: radiolytic reduction and cytotoxicity characteristics
K Tanabe et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Synthesis and photochemical properties of photoactivated antitumor prodrugs releasing 5-fluorouracil
Z Zhang et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2005)
Drug-induced increase of carcinoembryonic antigen expression in cancer cells
A Aquino et al.
PHARMACOLOGICAL RESEARCH (2004)
Enzyme-catalyzed activation of anticancer prodrugs
M Rooseboom et al.
PHARMACOLOGICAL REVIEWS (2004)
In vitro and in vivo evaluation of novel antitumor prodrugs of 5-fluoro-2'-deoxyuridine activated by hypoxic irradiation
Y Shibamoto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
The design of drugs that target tumour hypoxia
WA Denny
AUSTRALIAN JOURNAL OF CHEMISTRY (2004)
One-electron reduction characteristics of N(3)-substituted 5-fluorodeoxyuridines synthesized as radiation-activated prodrugs
K Tanabe et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2003)
Comparison of 5-fluorouracil and 5-fluoro-2'-deoxyuridine as an effector in radiation-activated prodrugs
Y Shibamoto et al.
JOURNAL OF CHEMOTHERAPY (2002)
Design, synthesis, and biological evaluation of indolequinone phosphoramidate prodrugs targeted to DT-diaphorase
M Hernick et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Modifying rates of reductive elimination of leaving groups from indolequinone prodrugs: a key factor in controlling hypoxia-selective drug release
SA Everett et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Design, synthesis, photochemical properties and cytotoxic activities of water-soluble caged L-leucyl-L-leucine methyl esters that control apoptosis of immune cells
H Mizuta et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2002)
Indolequinone antitumor agents:: Correlation between quinone structure and rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase.: Part 2
E Swann et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Recognition and cleavage at the DNA major groove
EB Skibo et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2001)
N(1)-C(5′)-linked dimer hydrates of 5-substituted uracils produced by anodic oxidation in aqueous solution
H Hatta et al.
JOURNAL OF ORGANIC CHEMISTRY (2001)
In vivo evaluation of a novel antitumor prodrug, 1-(2′-oxopropyl)-5-fluorouracil (OFU001), which releases 5-fluorouracil upon hypoxic irradiation
Y Shibamoto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
New dendritic caged compounds:: Synthesis, mass spectrometric characterization, and photochemical properties of dendrimers with α-carboxy-2-nitrobenzyl caged compounds at their periphery
S Watanabe et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2000)
5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development
JL Grem
INVESTIGATIONAL NEW DRUGS (2000)
Stereoelectronic effect on one-electron reductive release of 5-fluorouracil from 5-fluoro-1-(2′-oxocycloalkyl)uracils as a new class of radiation-activated antitumor prodrugs
M Mori et al.
JOURNAL OF ORGANIC CHEMISTRY (2000)
A novel class of antitumor prodrug, 1-(2′-oxopropyl)-5-fluorouracil (OFU001), that releases 5-fluorouracil upon hypoxic irradiation
Y Shibamoto et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2000)
Using photolabile ligands in drug discovery and development
G Dormán et al.
TRENDS IN BIOTECHNOLOGY (2000)
Share Paper
